Designing Early Clinical Development for Better Decisions and Faster Progression
On 9 December 2026, Medicon Valley Alliance hosts a Good Morning Meeting in Copenhagen on the design of early clinical development. Speakers from SGS examine Phase I study design, including combined SAD/MAD studies, early patient cohorts and adaptive protocols. They show how each option affects the time it takes to reach clinically meaningful data.
It will interest people working in clinical development, regulatory affairs and business strategy at pharmaceutical and biotechnology companies. The focus falls on how design choices feed into funding, partnering and portfolio decisions, with real-world case examples throughout.
The meeting runs from 8:30 to 11:00 and includes breakfast and networking. Participation requires registration; sign up here.
